• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Child-Turcotte Classification: From Gestalt to Sophisticated Statistics and Back.

作者信息

Garcia-Tsao Guadalupe

机构信息

Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar St - 1080 LMP, New Haven, CT, 06510, USA.

Section of Digestive Diseases, VA-CT Healthcare System, West Haven, CT, USA.

出版信息

Dig Dis Sci. 2016 Nov;61(11):3102-3104. doi: 10.1007/s10620-016-4319-7.

DOI:10.1007/s10620-016-4319-7
PMID:27696097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5218597/
Abstract
摘要

相似文献

1
The Child-Turcotte Classification: From Gestalt to Sophisticated Statistics and Back.儿童-图尔科特分类法：从整体观到精密统计学，再回归整体观
Dig Dis Sci. 2016 Nov;61(11):3102-3104. doi: 10.1007/s10620-016-4319-7.
2
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?系统评价：终末期肝病模型——它是否应取代Child-Pugh分级来评估肝硬化的预后？
Aliment Pharmacol Ther. 2005 Dec;22(11-12):1079-89. doi: 10.1111/j.1365-2036.2005.02691.x.
3
[New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].[肝硬化和肝细胞癌严重程度结局的新评分系统：关于Child-Turcotte-Pugh评分和终末期肝病模型（MELD）评分的当前问题]
Taehan Kan Hakhoe Chi. 2003 Sep;9(3):167-79.
4
The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.肝硬化患者腹腔内手术的安全性：终末期肝病模型评分在预测预后方面优于Child-Turcotte-Pugh分级。
Arch Surg. 2005 Jul;140(7):650-4; discussion 655. doi: 10.1001/archsurg.140.7.650.
5
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.肝细胞癌合并 Child-Pugh-Turcotte 级肝硬化患者的非移植治疗方法。
Lancet Oncol. 2017 Feb;18(2):e101-e112. doi: 10.1016/S1470-2045(16)30569-1.
6
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.一种从国家电子医疗数据库估算Child-Turcotte-Pugh评分的算法的开发与性能
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2333-41.e1-6. doi: 10.1016/j.cgh.2015.07.010. Epub 2015 Jul 15.
7
A confusing relationship between Child-Turcotte-Pugh class A and compensated cirrhosis.Child-Turcotte-Pugh A级与代偿期肝硬化之间令人困惑的关系。
Am J Gastroenterol. 2010 Feb;105(2):470-2; author reply 472. doi: 10.1038/ajg.2009.626.
8
Adding variceal status to Child-Turcotte-Pugh score improves its performance in predicting early mortality in cirrhosis: the Child-Turcotte-Pugh-Kumar score.将静脉曲张状态纳入Child-Turcotte-Pugh评分可提高其预测肝硬化早期死亡率的效能：Child-Turcotte-Pugh-Kumar评分。
Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1348-9. doi: 10.1097/MEG.0b013e3283579475.
9
Hepatic ADC value correlates with cirrhotic severity of patients with biliary atresia.肝脏 ADC 值与胆道闭锁患者肝硬化严重程度相关。
Eur J Radiol. 2011 Dec;80(3):e253-7. doi: 10.1016/j.ejrad.2010.11.002. Epub 2010 Nov 30.
10
Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.肝硬化患者手术后的死亡率：Child-Turcotte-Pugh、MELD 和 MELDNa 评分的比较。
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):51-9. doi: 10.1097/MEG.0b013e3283407158.

引用本文的文献

1
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.伴有门静脉癌栓的肝细胞癌的局部区域治疗
J Gastrointest Cancer. 2025 Jul 23;56(1):162. doi: 10.1007/s12029-025-01280-2.
2
Intravenous versus oral 'L-ornithine-L-aspartate' in overt hepatic encephalopathy: a randomized comparative study.静脉内与口服“L-鸟氨酸-L-天冬氨酸”治疗显性肝性脑病：一项随机对照研究。
Sci Rep. 2024 May 24;14(1):11862. doi: 10.1038/s41598-024-62293-8.
3
Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score.

本文引用的文献

1
Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.重新校准Child-Turcotte-Pugh评分以改善肝硬化患者无移植生存期的预测
Dig Dis Sci. 2016 Nov;61(11):3309-3320. doi: 10.1007/s10620-016-4239-6. Epub 2016 Jul 12.
2
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.一种从国家电子医疗数据库估算Child-Turcotte-Pugh评分的算法的开发与性能
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2333-41.e1-6. doi: 10.1016/j.cgh.2015.07.010. Epub 2015 Jul 15.
3
肝移植受者的死亡率评分系统：终末期肝病模型评分前后
Anesth Pain Med (Seoul). 2023 Jan;18(1):21-28. doi: 10.17085/apm.22258. Epub 2023 Jan 30.
4
Assessment of frailty in cirrhosis using bedside measures and its correlation with Child-Turcotte-Pugh, MELD & MELD-Na Scores.使用床边测量方法评估肝硬化患者的衰弱状况及其与Child-Turcotte-Pugh、MELD和MELD-Na评分的相关性。
Pak J Med Sci. 2022 May-Jun;38(5):1086-1092. doi: 10.12669/pjms.38.5.5545.
5
Assessment of liver cirrhosis severity with extracellular volume fraction MRI.用细胞外容积分数 MRI 评估肝硬化严重程度。
Sci Rep. 2022 Jun 8;12(1):9422. doi: 10.1038/s41598-022-13340-9.
6
The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting.资源有限环境下复发性丙型肝炎病毒感染再治疗的结果
Virusdisease. 2021 Sep;32(3):582-588. doi: 10.1007/s13337-021-00712-4. Epub 2021 Jul 27.
7
Malnutrition in Patients with Liver Cirrhosis.肝硬化患者的营养不良。
Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540.
8
Serum Ferritin Levels: A Potential Biomarker to Represent Child-Turcotte-Pugh Score among Decompensated Liver Cirrhosis Patients.血清铁蛋白水平：失代偿期肝硬化患者中代表Child-Turcotte-Pugh评分的潜在生物标志物。
Malays J Med Sci. 2019 Mar;26(2):59-65. doi: 10.21315/mjms2019.26.2.7. Epub 2019 Apr 30.
9
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.预防复发性静脉曲张出血的风险分层：一项个体患者荟萃分析的结果
Hepatology. 2017 Oct;66(4):1219-1231. doi: 10.1002/hep.29267. Epub 2017 Aug 26.
Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis.
血清白蛋白可识别预后良好的代偿期肝硬化患者。
J Clin Gastroenterol. 2015 Aug;49(7):613-9. doi: 10.1097/MCG.0000000000000207.
4
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.慢性肝病中的肝性脑病：美国肝病研究协会和欧洲肝脏研究协会2014年实践指南
Hepatology. 2014 Aug;60(2):715-35. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
5
Subclinical ascites defines an intermediate stage between compensated and decompensated cirrhosis.亚临床腹水定义了代偿期和失代偿期肝硬化之间的一个中间阶段。
Z Gastroenterol. 2012 Sep;50(9):996-1001. doi: 10.1055/s-0031-1299446. Epub 2012 Sep 10.
6
Muscle wasting is associated with mortality in patients with cirrhosis.肌肉减少症与肝硬化患者的死亡率相关。
Clin Gastroenterol Hepatol. 2012 Feb;10(2):166-73, 173.e1. doi: 10.1016/j.cgh.2011.08.028. Epub 2011 Sep 3.
7
A model to predict survival in patients with end-stage liver disease.一种预测终末期肝病患者生存率的模型。
Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.
8
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.预测经颈静脉肝内门体分流术患者生存预后不良的模型。
Hepatology. 2000 Apr;31(4):864-71. doi: 10.1053/he.2000.5852.
9
The treatment of portal hypertension: a meta-analytic review.门静脉高压症的治疗：一项荟萃分析综述
Hepatology. 1995 Jul;22(1):332-54. doi: 10.1002/hep.1840220145.
10
Surgery and portal hypertension.手术与门静脉高压症
Major Probl Clin Surg. 1964;1:1-85.